We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Age Gender Left Ventricular Mass and Cardiac Troponin T

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01100710
First Posted: April 9, 2010
Last Update Posted: April 9, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Heidelberg University
  Purpose
The purpose of this study is to determine the influence of functional or anatomic cardiac parameters, age and gender on high sensitivity cTnT (TnThs) levels in healthy individuals.

Condition
Heart Failure

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Relative Contribution of Age, Gender and Left Ventricular Mass as Quantified by Cardiac Magnetic Resonance Tomography to Detectable Levels of Cardiac Troponin T in a Healthy Reference Population Aged Below 70 Years

Further study details as provided by Heidelberg University:

Enrollment: 116
Study Start Date: March 2007
Study Completion Date: December 2009
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
healthy volunteers

Detailed Description:
We sought to investigate the relative contribution of functional or anatomic parameters as assessed by cardiac magnetic resonance tomography (cMRI, 1.5 Tesla), and clinical variables including increasing age and gender on high sensitivity cTnT (TnThs) levels in healthy individuals. Therefore we measured TnThs in serum samples of 120 healthy volunteers aged between 20 and 70 years. All individuals underwent cMRI including stress testing using dobutamine or adenosine.TnThs concentrations were related to cMRI and clinical findings. Partial correlation, as well as linear and hierarchical regression analyses were used to identify independent predictors and their relative contribution for prediction of TnThs values.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
residents of Heidelberg and urban hinterland
Criteria

Inclusion Criteria:

  • agreement, age > 18 years, men and women

Exclusion Criteria:

  • measurable heart disease, any chronic or acute disease, intake of meds, hypertension, Diabetes
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01100710


Locations
Germany
University Hospital of Heidelberg
Heidelberg, Baden-Würtemberg, Germany, 69120
Sponsors and Collaborators
Heidelberg University
Investigators
Principal Investigator: Evangelos Giannitsis, Prof.
  More Information

Publications:
Responsible Party: Prof. Dr. med. E. Giannitsis, University Hospital Heidelberg
ClinicalTrials.gov Identifier: NCT01100710     History of Changes
Other Study ID Numbers: UHD
First Submitted: April 8, 2010
First Posted: April 9, 2010
Last Update Posted: April 9, 2010
Last Verified: February 2007

Keywords provided by Heidelberg University:
Age Gender left ventricular mass high sensitive Troponin T

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases